Pfizer, Flynn Appeal UK Fine over ‘Excessive’ Price of Anti-Epilepsy Phenytoin Sodium Capsules

Pfizer and Flynn Pharma have appealed a £84.2 million (US $112.5 million) fine from UK’s Competitions and Market Authority over the price of the anti-epilepsy phenytoin sodium capsules, contending the agency misevaluated their positions in the market and mischaracterized the price as “excessive.”
Source: Drug Industry Daily